Table 3. Characteristics of study population.
| Characteristic | Median (IQR) or frequency (%) |
|---|---|
| Age at diagnosis (years) | 66 (60–71) |
|
Year of diagnosis | |
| 1988–1995 | 393 (29%) |
| 1996–2000 | 558 (41%) |
| 2001–2006 | 403 (30%) |
| Pre-treatment PSA (ng ml−1) | 7.3 (4.2–12.9) |
| Family history PCa | 141 (11%) |
|
Biopsy gleason grade | |
| ⩽6 | 503 (37%) |
| 7 | 532 (39%) |
| ⩾8 | 288 (22%) |
| Unknown | 31 (2%) |
|
Clinical stage | |
| T1 | 576 (42%) |
| T2 | 512 (38%) |
| T3/4 | 201 (15%) |
| Unknown | 65 (5%) |
|
Type of treatment | |
| Radical prostatectomy | 466 (34%) |
| Radiotherapy±androgen deprivation | 804 (59%) |
| Androgen deprivation alone/WW | 84 (7%) |
Abbreviations: IQR=interquartile range; PCa=prostate cancer; PSA=prostate-specific antigen; WW=watchful waiting.